Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | 17-AAG | 0.01 | uM | 10 | 312.50 | 120.45 | 795.00 | 507.00 | 1.5680 | 1.4845 |
| MDA-MB-231 | Lapatinib | 1 | uM | 10 | 312.50 | 120.45 | 821.00 | 507.00 | 1.6193 | 1.5234 |
| MDA-MB-231 | Erlotinib | 0.0033113 | uM | 10 | 312.50 | 120.45 | 873.00 | 507.00 | 1.7219 | 1.5993 |
| MDA-MB-231 | Erlotinib | 0.31623 | uM | 10 | 312.50 | 120.45 | 764.00 | 507.00 | 1.5069 | 1.4373 |
| MDA-MB-231 | Lapatinib | 0.31623 | uM | 10 | 312.50 | 120.45 | 526.00 | 507.00 | 1.0375 | 1.0358 |
| MDA-MB-231 | Erlotinib | 10 | uM | 10 | 312.50 | 120.45 | 601.00 | 507.00 | 1.1854 | 1.1710 |
| MDA-MB-231 | Erlotinib | 19.9526 | uM | 10 | 312.50 | 120.45 | 352.00 | 507.00 | 0.6943 | 0.6773 |
| MDA-MB-231 | 17-AAG | 0.0033113 | uM | 10 | 312.50 | 120.45 | 460.00 | 507.00 | 0.9073 | 0.9083 |
| MDA-MB-231 | Lapatinib | 10 | uM | 10 | 312.50 | 120.45 | 364.00 | 507.00 | 0.7180 | 0.7046 |
| MDA-MB-231 | 0 | uM | 10 | 312.50 | 120.45 | 338.00 | 507.00 | 0.6667 | 0.6448 | |
| MDA-MB-231 | 0 | uM | 10 | 625.00 | 241.23 | 1132.00 | 1206.50 | 0.9383 | 0.9459 | |
| MDA-MB-231 | Linsitinib | 0.01 | uM | 10 | 625.00 | 241.23 | 1059.00 | 1206.50 | 0.8778 | 0.8908 |
| MDA-MB-231 | Linsitinib | 0.031623 | uM | 10 | 625.00 | 241.23 | 1361.00 | 1206.50 | 1.1281 | 1.1065 |
| MDA-MB-231 | 0 | uM | 10 | 625.00 | 241.23 | 1306.00 | 1206.50 | 1.0825 | 1.0694 | |
| MDA-MB-231 | 17-AAG | 1 | uM | 10 | 625.00 | 241.23 | 841.00 | 1206.50 | 0.6971 | 0.7122 |
| MDA-MB-231 | Linsitinib | 10 | uM | 10 | 625.00 | 241.23 | 1000.00 | 1206.50 | 0.8288 | 0.8447 |
| MDA-MB-231 | 17-AAG | 0.1 | uM | 10 | 625.00 | 241.23 | 1369.00 | 1206.50 | 1.1347 | 1.1118 |
| MDA-MB-231 | Lapatinib | 0.01 | uM | 10 | 625.00 | 241.23 | 1500.00 | 1206.50 | 1.2433 | 1.1966 |
| MDA-MB-231 | 17-AAG | 0.031623 | uM | 10 | 625.00 | 241.23 | 1407.00 | 1206.50 | 1.1662 | 1.1369 |
| MDA-MB-231 | Lapatinib | 0.1 | uM | 10 | 625.00 | 241.23 | 1505.00 | 1206.50 | 1.2474 | 1.1997 |
| MDA-MB-231 | Lapatinib | 0.031623 | uM | 10 | 625.00 | 241.23 | 1434.00 | 1206.50 | 1.1886 | 1.1544 |
| MDA-MB-231 | Linsitinib | 3.1623 | uM | 10 | 625.00 | 241.23 | 1249.00 | 1206.50 | 1.0352 | 1.0300 |
| MDA-MB-231 | 0 | uM | 10 | 625.00 | 241.23 | 1314.00 | 1206.50 | 1.0891 | 1.0749 | |
| MDA-MB-231 | Erlotinib | 0.1 | uM | 10 | 625.00 | 241.23 | 1358.00 | 1206.50 | 1.1256 | 1.1045 |
| MDA-MB-231 | Linsitinib | 0.31623 | uM | 10 | 625.00 | 241.23 | 1401.00 | 1206.50 | 1.1612 | 1.1329 |